These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 17215066)

  • 1. Framework for use of toxicity screening tools in context-based decision-making.
    Doull J; Borzelleca JF; Becker R; Daston G; DeSesso J; Fan A; Fenner-Crisp P; Holsapple M; Holson J; Craig Llewellyn G; MacGregor J; Seed J; Walls I; Woo YT; Olin S
    Food Chem Toxicol; 2007 May; 45(5):759-96. PubMed ID: 17215066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk management frameworks for human health and environmental risks.
    Jardine C; Hrudey S; Shortreed J; Craig L; Krewski D; Furgal C; McColl S
    J Toxicol Environ Health B Crit Rev; 2003; 6(6):569-720. PubMed ID: 14698953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advancing exposure characterization for chemical evaluation and risk assessment.
    Cohen Hubal EA; Richard A; Aylward L; Edwards S; Gallagher J; Goldsmith MR; Isukapalli S; Tornero-Velez R; Weber E; Kavlock R
    J Toxicol Environ Health B Crit Rev; 2010 Feb; 13(2-4):299-313. PubMed ID: 20574904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Procedures and methods of benefit assessments for medicines in Germany].
    Bekkering GE; Kleijnen J
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a preliminary framework for informing the risk analysis and risk management of nanoparticles.
    Morgan K
    Risk Anal; 2005 Dec; 25(6):1621-35. PubMed ID: 16506988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The contrast between risk assessment and rules of evidence in the context of international trade disputes: can the US experience inform the process?
    Anderson EL; Hilaire CS
    Risk Anal; 2004 Apr; 24(2):449-59. PubMed ID: 15078316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk analysis for environmental health triage.
    Bogen KT
    Risk Anal; 2005 Oct; 25(5):1085-95. PubMed ID: 16297216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tiered chemical testing: a value of information approach.
    Yokota F; Gray G; Hammitt JK; Thompson KM
    Risk Anal; 2004 Dec; 24(6):1625-39. PubMed ID: 15660617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reflections on uncertainty in risk assessment and risk management by the Society of Environmental Toxicology and Chemistry (SETAC) precautionary principle workgroup.
    Sanderson H; Stahl CH; Irwin R; Rogers MD
    Water Sci Technol; 2005; 52(6):73-9. PubMed ID: 16304937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human health and endocrine disruption: a simple multicriteria framework for the qualitative assessment of end point specific risks in a context of scientific uncertainty.
    Martin OV; Lester JN; Voulvoulis N; Boobis AR
    Toxicol Sci; 2007 Aug; 98(2):332-47. PubMed ID: 17255114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meeting the common needs of a more effective and efficient testing and assessment paradigm for chemical risk management.
    Dellarco V; Henry T; Sayre P; Seed J; Bradbury S
    J Toxicol Environ Health B Crit Rev; 2010 Feb; 13(2-4):347-60. PubMed ID: 20574907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Framework for metals risk assessment.
    Fairbrother A; Wenstel R; Sappington K; Wood W
    Ecotoxicol Environ Saf; 2007 Oct; 68(2):145-227. PubMed ID: 17889701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Linguistic uncertainty in qualitative risk analysis and how to minimize it.
    Carey JM; Burgman MA
    Ann N Y Acad Sci; 2008 Apr; 1128():13-7. PubMed ID: 18469210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decision-making in environmental health.
    Schwartz E; Corvalán C
    World Health Stat Q; 1995; 48(2):164-70. PubMed ID: 8585235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancing the ecological risk assessment process.
    Dale VH; Biddinger GR; Newman MC; Oris JT; Suter GW; Thompson T; Armitage TM; Meyer JL; Allen-King RM; Burton GA; Chapman PM; Conquest LL; Fernandez IJ; Landis WG; Master LL; Mitsch WJ; Mueller TC; Rabeni CF; Rodewald AD; Sanders JG; van Heerden IL
    Integr Environ Assess Manag; 2008 Jul; 4(3):306-13. PubMed ID: 18324871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shared decision-making in the context of menopausal health: where do we stand?
    Légaré F; Brouillette MH
    Maturitas; 2009 Jul; 63(3):169-75. PubMed ID: 19272720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancing the credibility of decisions based on scientific conclusions: transparency is imperative.
    Schreider J; Barrow C; Birchfield N; Dearfield K; Devlin D; Henry S; Kramer M; Schappelle S; Solomon K; Weed DL; Embry MR
    Toxicol Sci; 2010 Jul; 116(1):5-7. PubMed ID: 20363830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk-based maintenance--techniques and applications.
    Arunraj NS; Maiti J
    J Hazard Mater; 2007 Apr; 142(3):653-61. PubMed ID: 16887261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of the BRAT framework to case studies: observations and insights.
    Levitan BS; Andrews EB; Gilsenan A; Ferguson J; Noel RA; Coplan PM; Mussen F
    Clin Pharmacol Ther; 2011 Feb; 89(2):217-24. PubMed ID: 21178990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.